Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

被引:1
作者
Lin, Ziwei [1 ]
Si, Si [1 ]
Liu, Jia [2 ]
Zhu, Hao [1 ]
Xu, Jiawei [1 ]
Artime, Esther [3 ]
Khare, Swarna [4 ]
Higgins, Victoria [5 ]
Leith, Andrea [5 ]
Qu, Shen [2 ,6 ]
机构
[1] Eli Lilly & Co, Suzhou, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Endocrinol & Metab Ctr, Sch Med, Shanghai, Peoples R China
[3] Eli Lilly & Co, Alcobendas, Spain
[4] Eli Lilly & Co, Bracknell, England
[5] Adelphi Real World, Bollington, England
[6] SinoUnited Hlth, Endocrinol Metab & Thyroid Ctr, Shanghai, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
China; dietary intervention; obesity therapy; real-world evidence; weight control; OBESITY; OVERWEIGHT;
D O I
10.3389/fendo.2024.1470394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To describe weight management and perceptions in China.Materials and methods Data were from the Adelphi Real World Obesity Disease Specific Programme (TM), a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged >= 18 years, under weight management and/or had a body mass index (BMI) >= 28 kg/m2.Results In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI >= 30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).Conclusions These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [22] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Osama Hamdy
    Sahar Ashrafzadeh
    Adham Mottalib
    Current Diabetes Reports, 2018, 18
  • [23] Effect of weight loss on proteinuria in adults with type 2 diabetes: A real-world study
    Ren, Wenqian
    Gong, Yujia
    Zhen, Qin
    Gu, Liping
    Yang, Jiaying
    Kang, Mei
    Zhang, Aifang
    Shen, Tingting
    Wang, Yufan
    Liu, Fang
    Li, Na
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 206
  • [24] Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population
    Vargas, Eric J.
    Pesta, Carl M.
    Bali, Ahmad
    Ibegbu, Eric
    Bazerbachi, Fateh
    Moore, Rachel L.
    Kumbhari, Vivek
    Sharaiha, Reem Z.
    Curry, Trace W.
    DosSantos, Gina
    Schmitz, Ramsey
    Agnihotri, Abhishek
    Novikov, Aleksey A.
    Pitt, Tracy
    Dunlap, Margo K.
    Herr, Andrea
    Aronne, Louis
    Ledonne, Erin
    Kadouh, Hoda C.
    Cheskin, Lawrence J.
    Mundi, Manpreet S.
    Acosta, Andres
    Gostout, Christopher J.
    Abu Dayyeh, Barham K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (07) : 1073 - +
  • [25] Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
    Appel, Lawrence J.
    Clark, Jeanne M.
    Yeh, Hsin-Chieh
    Wang, Nae-Yuh
    Coughlin, Janelle W.
    Daumit, Gail
    Miller, Edgar R., III
    Dalcin, Arlene
    Jerome, Gerald J.
    Geller, Steven
    Noronha, Gary
    Pozefsky, Thomas
    Charleston, Jeanne
    Reynolds, Jeffrey B.
    Durkin, Nowella
    Rubin, Richard R.
    Louis, Thomas A.
    Brancati, Frederick L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21) : 1959 - 1968
  • [26] Medications and conditions associated with weight loss in patients prescribed semaglutide based on real-world data
    Powell, William
    Song, Xing
    Mohamed, Yahia
    Walsh, Dave
    Parks, Elizabeth J.
    McMahon, Tamara M.
    Khan, Mirza
    Waitman, Lemuel R.
    OBESITY, 2023, 31 (10) : 2482 - 2492
  • [27] Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population
    DerSarkissian, Maral
    Bhak, Rachel H.
    Huang, Joanna
    Buchs, Sarah
    Vekeman, Francis
    Smolarz, B. Gabriel
    Brett, Jason
    Ganguly, Rahul
    Duh, Mei Sheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (06) : 1105 - 1110
  • [28] Real-World Clinical Effectiveness of Liraglutide for Weight Management in Türkiye: Insights from the LIRA-TR Study
    Oral, Alihan
    Kucuk, Celalettin
    Kose, Murat
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [29] Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases
    Murray-Thomas, Tarita
    Dcruz, John M.
    Harder-Lauridsen, Nina M.
    Olsen, Anne H.
    Williams, Rachael
    Major-Pedersen, Atheline
    DIABETES OBESITY & METABOLISM, 2025,
  • [30] Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice
    Pantanetti, Paola
    Cangelosi, Giovanni
    Alberti, Sara
    Di Marco, Sandra
    Michetti, Grazia
    Cerasoli, Gianluca
    Di Giacinti, Marco
    Coacci, Silvia
    Francucci, Nadia
    Petrelli, Fabio
    Ambrosio, Giuseppe
    Grinta, Roberto
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15